Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe

 

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

This strategic analysis service provides detailed analysis of royalty issues and its affects on pharmaceutical products. The service in powerpoint format (approximately 75 slides) focuses not just only on the problems with royalty stacking, patents and problems with commercialisation of biotechnology but also on strategies for resolution of these problems.

Table of Contents

Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe, Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in EuropeOverviewOverviewResearch Scope and MethodologyResearch Scope and MethodologyIntroductionGeneral Introduction and BackgroundPatent EnvironmentPatent EnvironmentRoyalty Stacking EnvironmentRoyalty Stacking EnvironmentSolutions to Royalty StackingSolutions to Royalty StackingManaging RoyaltiesManaging RoyaltiesStrategic RecommendationsStrategic RecommendationsIndustry ParticipantsIndustry ParticipantsDecision Support DatabasesDecision Support DatabasesAbout Frost & SullivanOur TeamConsulting Capabilities




Related Research

Release Date : 13-Oct-17

Region : Global

Release Date : 13-Oct-17

Region : Global

Release Date : 11-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.